As the Global Head of Early Development Biometrics, you will provide strategic leadership and oversight across Biometrics functions - e.g., Biostatistics, Statistical and Analytical Programming, Data Management - to ensure a cohesive and high-performing collective function that drives excellence in service of our strategy through deep partnership with Roche early development groups. You will also oversee Biometrics-wide capabilities including innovative methods and analytical / digital enablers embedded within our workflows and processes. You will report to the Global Head, PD Data Sciences & Analytics (PD-DSA), and you will be responsible for shaping the early development strategy across all core Biometrics capabilities and therapeutic areas in alignment with broader PD-DSA and company objectives, as well as your organization's overall performance. You will shape the strategy and execution for early development trials at Roche by partnering closely and influencing activities across Biostatistics, Statistical and Analytical Programming, and Data Management as they pertain to the early development portfolio. You will ensure scientific rigor, innovative approaches, and high-quality data solutions, all in service of accelerating decision-making and insights generation for early-phase clinical trials. Your team will leverage cutting-edge analytics, data standards, and automation to ensure delivery of timely, high-quality insights that inform critical decisions in early drug development. You will lead a global, high-performing organization of approximately 75-100 early development-focused professionals, including Biostatisticians, Statistical Programmers, and Data Managers, to support the unique demands of early development. Your direct reports will be a team of directors and above.